Business Standard

Krsnaa Diagnostics lists at 7% premium over issue price on BSE

The initial public offer (IPO) of KDL got a strong response from the investors as the issue got subscribed 64.38 times

share buybacks, investment, stock market, sensex, bse, nifty, investors, cash, fund, fdi, fpi, shares, listings, ipo
Premium

SI Reporter Mumbai
Krsnaa Diagnostics (KDL) made a decent debut on the bourses with the shares of the company getting listed at Rs 1,025, a 7.4 per cent premium against issue price of Rs 954 per share on the BSE. On the National Stock Exchange (NSE), the stock of healthcare services company opened at Rs 1,006, a 5.5 per cent higher against its issue price.

At 10:07 am; the stock was quoting at Rs 1,085.45, up 14 per cent higher against issue price. It hit a high of Rs 1,099.50 and low of Rs 961.45 on the BSE so far. A combined

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in